The in vivo action of heparin on plasma lipids was initially observed by Hahn to be a clearing of a lipemic plasma of its light scattering components ( 1 ) . Such action definitely suggested a transformation of the physical state of the plasma lipids. The work of Gofman and co-workers at this laboratory has shown that the different plasma lipids measured chemically could be accounted for in the spectrum of lipoprotein molecules ( 2 ) . The action of heparin on the lipemic plasma indicated its probable involvement with this whole spectrum of lipid-bearing molecules. The action of in vivo heparin on the spectrum was observed by Graham and co-workers and subsequently studied by Lindgren and coworkers at this laboratory (3, 4) . Their investigations bring forth the observation that subsequent to an injection of heparin there is a uni-directional transformation of lipid-bearing molecules from the ultracentrifugally defined high Sf (molecules of high glyceride content) to the lower Sf values (which are correspondingly lower in glycerides). Such transformations could be produced in vitro by incubation of a lipemic serum with in vivo heparinized plasma. This report presents an investigation of the interaction of the active principle or factor of heparinized plasma with lipoprotein species isolated from egg yolk( 5 ) . The interaction was manifested by a reduction in the optical density of a solution containing a small amount of ELP (egg lipoprotein) maintained at a low ionic strength and pH 6.7. Addition of heparin in low concentrations to the dilute ELP solution increased the optical density. Thus. there was present in post heparin plasma an agent which altered the *This work was supported in part by the U. S. solubility characteristics of the ELP solution and which could not be reproduced by a simple in vitro addition of heparin.
Atomic Energy Commission and by the Lederle
Mcthods. The ELP was obtained by means of a 12-hour preparative ultracentrifugation at 30,000 RPM (Spinco preparative centrifuge and 30.2 rotor) of egg yolk contents diluted in the proportion one yolk to 18 ml phosphate buffer (pH 8.0; ionic strength 0.1). The lipoprotein forms a yellow concentrate in the uppermost zone of the centrifuge tube. This concentrate is carefully removed and when diluted one to 4 parts with the above buffer serves as a stock solution (concentration approx. 5 % ) . An analytical ultracentrifugation (in density 1.0630 at 26°C at 52,640 RPM) determines the concentration and any sedimenting contamination, which is to be avoided, in the stock solution. Under the above conditions the lipoprotein preparation has a major component of approx. [25] [26] [27] [28] [29] [30] Sr units with some faster species generally present. Infra-red chemical analyses by Freeman (6) give an average composition for the preparation as follows: Glyceryl ester, 67% ; cholesterol (predominantly free), 6% ; phospholipid (as lecithin), 16% ; protein, 11 %.
For measurements on the interaction system of ELP with either pre-heparin serum: or postheparin plasma6 the technic was to incubate 0.1 ml of a 3 to 5% ELP solution with 0.1 ml of serum or plasma a t 37°C for a specified time. At the end of the incubation period the mixture was diluted with 10 ml of an appropriate buffer (depending on required pH value), stirred, and allowed to stand for 15 minutes. After this period the diluted mixture was stirred and the optical transmission at 650 mp (Beckman spectrophotometer) was measured. The QH of the incubation mixture was controlled around pH 8.0 in order to operate in the neighborhood of maximal increase in transmission as shown in Fig. 5 .
Results. As shown in Fig. 1 the ELP solubility is increased by an increase in ionic strength and is at a minimum in the region of pH 6.7. Fig. 2 shows that at a constant ionic strength of 0.01, there is a marked difference in solubility, when the effects of pre-heparin serum and post-heparin plasma on the ELP are compared. The shift in the point of minimum solubility, or what may be expressed alternatively, the increased solubility of the ELP in a given region of pH, at ionic strength 0.01, was observed only if one or more of the following conditions were met: 1) the postheparin plasma was obtained from an individual whose blood contained an elevated level of lipoprotein species of high glyceride content. 2 ) the post-heparin plasma, ob-Pre-heparin serum obtained from untrea4ed whole blood from an individual prior to intravenous administration of heparin.
$ Post-heparin plasma obtained from whole blood drawn from an individual after intravenous administration of heparin.
tained from a fasting individual normally low in the glyceride-containing lipoprotein species, was incubated with a lipemic serum prior to the addition of ELP. 3) a fasting postheparin plasma, again from an individual low in glyceride-containing lipoproteins, was incubated with ELP before testing for activity. This condition is illustrated by comparison of Fig. 3 with Fig. 2 (incubated versus non-incubated systems in which plasma came from a fasting individual low in glyceride-containing lipoproteins). Thus, an essential requirement for the production of the shift in ELP solubility was a pior interaction-either in vivo or in vitro at 37'C-of heparinized plasma with lipoprotein species high in glyceride content.
The necessity for the presence of lipoproteins high in glycerides to enable post-heparin plasma to increase the solubility of ELP indicated that there may be the release of a labile lipid constituent which itself may effect the alteration. Such a constituent does not alter the pH of the system to a significant degree under the conditions of the solubility determination. Therefore, it might be supposed that a soluble agent with a very high surface activity such as a fatty acid soap is released during the interaction. Fig. 4 shows the effect of sodium oleate on ELP, and that it is analogous to the post-heparin plasma interaction effect shown in Fig. 2 .
Data from rate determinations are shown in Figs. 6 and 7 . The reaction was stopped with the addition of 10 ml of cacodylate buffer (ionic strength 0.01; pH 6.7). A plot after a single 50 mg intravenous injection of heparin as measured under the conditions already described for rate studies, is shown in Fig. 8 . Within 3 hours after the heparin injection the serum of this subject no longer had any demonstrable effect. Following intravenous injections of 100 mg the effect was observed to persist for 4 to 5 hours. Again, in Fig. 8 , it should be noted that measurement of transmission without prior incubation of the ELP with the plasma reveals no change following the heparin injection because of the initial low level of glyceride in this subject's serum. Further chemical investigations at this laboratory have substantiated this is obtained by analytical ultracentrifugation) is also designated C, cone. and any dilution thereof with appropriate buffer is a fraction of that C, cone.
hypothesis by showing that fatty acid is indeed liberated with $a concomitant decrease in triglycerides when lipoproteins high in glyceride content are incubated with postheparin plasma('/). Further studies are in progress toward establishing the type of reaction scheme in the above system and its dependence on the concentration of the reac tan ts . ; any dilution thereof with preheparin plasma or serum is deaignated aa a fraction of C, . Egg lipoprotein (ELP) atock sol. (whose actual mnc. is obtained by analytical ultracentrifugation) is also designated C, conc. and any dilution thereof with appropriate buffer ie a fraction of that C, conc. 
